4Kariyawasma HH, Aizen M, Barkans J, et al. Remodeling andairway hyperresponsiveness hut not cellular inflamination persist after allergen challenge in asthma. Am J Respir Crit Core Med, 2007,175(9) :896-904.
5Price D, Thomas M. Breaking new ground.-challenging existing asthma guidelines. BMC Pulm Med,2006,6(suppl 1 ) :$6.
6Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest,2006,129(4) : 1068-1087.
7Zuyderduyn S, Sukkar MB, Fust A, et al. Treating asthma means treating airway smooth muscle cells. Eur Respir J, 2008,32 (2) : 265-274.
8Tang ML, Wilson JW, Stewart AG, et al. Airway remodeling in asthma current understanding and imp|icatons for future thera- pies. Pharmacol Ther,2006,112(2) :474 488.
9Marx JL. The fos gene as "master switch" J . Science, 1987,237 (4817) :854--856.
10Wickremasinghe MI, Thomas LH, OKane CM, et al. Transcrip- tional mechanisms regulating alveolar epithelial cell-specific cc15 secretion in pulmonary tuberculosis J . Biol Chem,2004,279(26) : 27199-27210.
